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Abstract
Background: Psychiatric disorders are common in irritable bowel syndrome (IBS) patients. The prevalence of
psychiatric disorders in IBS patients varies in different cultures. We conducted this study to determine the
prevalence of psychiatric disorders
Methods: In a cross-sectional study, 256 IBS patients were selected (using the criteria of Rome III) and evaluated
for psychiatric disorders. In the first phase, subjects were screened using the General Health Questionnaire 28
(GHQ28). In the second phase, those who had scores ≥ 23 were assessed through semi-structured psychiatric
interviews.
Results: Thirty out of 256 subjects had no significant psychiatric symptoms after performing GHQ28. In further
psychiatric evaluation of the remaining subjects (226) who suffered from some degree of a psychiatric problem, 36
were diagnosed without Anxiety/Depressive disorder. Thus 66 subjects (25.8%) were known as a group without any
significant psychiatric problem. A total of 190 subjects (74.2%) with anxiety-depressive problems were diagnosed;
89 were suffering from pure anxiety disorders, 41 were suffering from depressive disorders and 60 had co-morbid
anxiety-depressive disorders. When comparing anxiety-depressive patients (n = 190) with normal subjects (n = 66),
gender (P = 0.016), occupation (P = 0.002) and intensity of IBS (P < 0.001) showed statistically significant
differences.
Conclusion: The high prevalence of anxiety-depressive disorders in this study indicates the necessity of psychiatric
assessment, early diagnosis and treatment of the patients with IBS. It may improve management of the patients
suffering from IBS.
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Background
Irritable bowel syndrome (IBS) is a malfunction of the
intestine that is characterized by abdominal pain and/or
abdominal discomfort and changes in bowel habits with-
out any detected structural disorders. Ten to twenty
percent of adults and teenagers worldwide have some
signs of IBS. It is more common in females and less
common in the elderly (more than 60 years old). Less
than one-third of these patients visit practitioners,
which accounts for about 12% of primary care visits.
The severity of symptoms is varied and it may have
some effects on patient quality of life and increases
healthcare costs [1]. The pathophysiology of IBS is still
poorly understood, thus the treatment of IBS is mainly
directed toward symptoms.
It has been shown that patients with the most intense
symptoms have the worst quality of life, and the mor-
bidity of IBS is equal to severe organic gastrointestinal
diseases. IBS is the second cause of absence from work
(after the common cold) and it is almost 3 times more
than other workers [2]. In a survey of 8 European coun-
tries, a randomized cluster sampling of 41,984 indivi-
duals, patients with IBS were identified. After
psychiatric evaluation, 78 percent of them believed that
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IBS had some effect on their health state and quality of
life which in 24% these effects estimated as very signifi-
cant [3].
Several studies have evaluated the relation between
IBS and psychiatric disorders [4-6]. It has been reported
that neurosis, anxiety, depression, and dysfunctional
cognition are more prevalent in patients with IBS [7-11].
In a large randomized controlled trial Guthrie et al.
found that 44% of IBS patients had psychiatric comor-
bidity which depressive and anxiety disorders were the
most common conditions [12]. In a study by Yates, six
major gastrointestinal features including: abdominal
pain, diarrhea, bloating, constipation, loss of appetite
and vomiting were considered along with the psychiatric
state of the patients. Major depression (13.4%), panic
disorder (12.5%) and agoraphobia (17.8%) were found to
be more common in patients with 2 or more GI symp-
toms [13]. A most recent study provided further evi-
dence that GI specific anxiety is an important mediating
factor affecting the GI symptom severity and quality of
life in IBS patients. This study concluded that reduction
of gastrointestinal specific anxiety in IBS could be a
relevant treatment goal to achieve general improvement
in patients with IBS [14]. The prevalence of anxiety-
depressive disorders in IBS patients differs according to
the studied population, study type, sample size and
methodology of the research. In northern part of Iran,
there was no available data on the psychiatric evaluation
of the patients with IBS. Therefore this study was
designed to determine the prevalence of psychiatric dis-
orders in the IBS patients of the Guilan province.
Methods
In this cross-sectional study we included patients diag-
nosed as IBS cases. In a preliminary pilot study on 24
IBS patients, the prevalence of phobia, major depres-
sion, generalized anxiety and dysthymia were 29.4%,
29.4%, 41.2% and 41.2%, respectively. Therefore, con-
sidering a = 0.05, d = 0.056 and prevalence = 29.4%,
(N = P.(1-P).Z2/d2), we enrolled 256 IBS patients in
this study. These patients were recruited from gastro-
enterology private clinics, and then were referred to
the “Psychiatrics” who worked in Gastrointestinal and
Liver Disease Research Center (GLDRC), Rasht the
capital city of Guilan province in northern Iran. The
gastroenterologists chose them randomly from IBS
patients who had been referred to their private clinics
during January 2009 to June 2009. They referred the
first one then omitted the second and referred the
third one and so on. Therefore, 256 subjects out of
512 IBS patients were included in this study. The
inclusion criteria were: diagnosed with IBS by physi-
cian according to the Roma III criteria, age between
15-80 and willing to enroll in the research.
This study was performed in two phases. In the first
phase, the probable cases of depression or anxiety were
detected with the self-reporting General Health Ques-
tionnaire 28 (GHQ28). In the second phase, the patients
who scored > 23 of GHQ28, underwent a semi-struc-
tured clinical interview using the DSM IV-TR to evalu-
ate anxiety-depressive disorders.
The standardized GHQ28 test in Iran was shown to
have a sensitivity and specificity of 84 - 88% and 78 -
93%, respectively, validity of 85 - 90%, an overall classi-
fied error of 8.2 - 19%, best scoring of 0, 1, 2 and 3 and
best cut off point of 23 [15]. The questionnaire had four
scales (somatic, anxiety and sleeping disorders, major
depression, and social dysfunction). Each scale consisted
of 7 questions and each question had four choices with
a score of 0 to 3. Two residents of psychiatry, who were
qualified on using the semi-structural Diagnostic and
Statistical Manual of Mental Disorders, 4th edition
(DSM IV-TR) interview and after reaching an acceptable
correlation rate, initiated the survey. The IBS cases that
had previously been diagnosed using the Rome III cri-
teria [16] were randomly selected from the gastroenter-
ology private clinics. Demographic information (e.g.,
age, sex, occupational and marital status and educational
level) was obtained and the GHQ28 was given to them
to be filled out in 20 min. In the case of illiterate parti-
cipants, the interviewer assisted them with filling out
the forms.
From 256 patients, who referred by the gastroenterol-
ogists, 30 had a GHQ 28 < 23 so they considered nor-
mal and from the remaining (226); 36 were without
Anxiety/Depressive disorder, although, they had some
psychiatric signs, they did not have any psychiatric dis-
orders. Thus we had 190 IBS patients with Anxiety-
Depressive disorders compare with 66 IBS patients with-
out any psychiatric disorders.
Psychiatric assessment
Judgment on the psychiatric state of studied IBS patients
was carried out using the GHQ28 and semi-structured
psychiatric interviews and patients were subsequently
divided into 4 groups as presented in Table 1.
Diagnostic criteria for IBS [11] were defined as having
recurrent abdominal pain or discomfort at least 3 days
per month in the last 3 months associated with 2 or
more of the following:
1. Improvement with defecation
2. Onset associated with a change in frequency of
stools
3. Onset associated with a change in form (appear-
ance) of stools
These criteria were fulfilled for the previous 3 months
with symptom onset at least 6 months prior to
diagnosis.
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Subtyping IBS by predominant stool pattern
Subtyping IBS using the predominant stool pattern [16]
was carried out using the criteria presented in Table 2.
Although the above sub-classifications may be used to
subtype patients according to bowel habits, the validity
and stability of such subtypes over time is unknown. IBS
severity scores were based on five visual analogue scales:
severity of pain, duration of pain, abdominal bloating,
bowel satisfaction and quality of life. Overall IBS severity
scores were expressed as a score from 0 (least severe) to
500 (most severe). Mild, moderate and severe cases were
indicated by scores of 75 to 175, 175 to 300 and > 300,
respectively [18]. The participants were asked about the
occupational and educational status as well.
Statistics analysis
We used descriptive tools for prevalence analysis, chi-
square tests for comparing qualitative variables (e.g., IBS
and depression), T-tests for quantitative variables and
kappa tests (> .75) for detecting the agreement coeffi-
cient between interviewers. P-values < 0.05 were consid-
ered statistically significant.
Ethical considerations
This study was approved by the ethic committees of
Guilan Gastrointestinal and Liver Disease Research Cen-
ter (GLDRC). We fully explained the study to the parti-
cipants (IBS patient with or without anxiety/depressive
disorder) and written consents were obtained. All pri-
vate information remained confidential and, when
needed, patients were referred to a psychiatrist for
appropriate treatment.
Results
Of 256 patients participated in this study, 156 (60.9%)
were females and 100 (39.1%) were males and 226
subjects (83 males and 143 females) suffered from a
degree of psychiatric problems (GHQ28 ≥ 23). After
performing semi-structured psychiatric interviews, 190
subjects (74.2%) had anxiety-depressive disorders (89
were suffering from anxiety disorders, 41 depressive dis-
order and 60 had co-morbid anxiety-depressive disor-
ders; Figures 1, 2).
The demographic variables of gender (P = 0.016),
occupation (P = 0.002) and intensity of IBS (P < 0.001),
in comparison with other subjects (66), showed statisti-
cally significant differences (Table 3).
In anxiety disorder cases, GAD was the most frequent,
and in depressive disorder cases, dysthymia was the
most frequent. There were statistically significant differ-
ences in age [mean age of 42.7 (s.d. = 13.4) vs. 37.1 (s.d.
= 12.4), P = 0.033], severity of disease (P < 0.001), edu-
cational level (P = 0.016) and marital status (P = 0.014)
between patients with depressive disorders (n = 41)
compared with psychiatrically normal cases (n = 66).
Comparing IBS patients that had anxiety disorders and
psychiatrically normal cases, there were significant dif-
ferences in the severity of disease (P < 0.001) and occu-
pational status (P = 0.002). Also, comparing patients
with anxiety and those with depressive disorders, IBS
patients with anxiety were younger [mean age of 33.0 (s.
d. = 10.6) vs. 42.7 (s.d. = 13.4) and P = 0. 01], more fre-
quently single (P = 0.01), had a higher educational status
(P = 0.024) and suffered more from IBS-D (P = 0.01;
Table 4).
Discussion
Several authors have emphasized the need for psycholo-
gical assessment in patients with functional bowel disor-
ders [10,19-21]. Different studies have shown that
almost two-thirds of all patients with self-reported
depressive symptoms were not identified by the
Table 1 Psychiatric state assessment of the IBS patients [17]
Normal Patients with a GHQ28 score < 23.
Depression The presence of at least one of the following disorders: major depressive disorder (MDD), minor depressive disorder or dysthymic
disorder.
Anxiety The presence of at least one of the following disorders: phobia, panic attacks, generalized anxiety disorder (GAD), obsessive-compulsive
disorder (OCD) or post-traumatic stress disorder (PTSD).
Co-morbid Having both anxiety and depression criteria simultaneously.
Table 2 Subtyping IBS using the predominant stool pattern [17]
IBS with constipation (IBS-
C)
Hard or lumpy stools for ≥ 25% of bowel movements and loose (mushy) or watery stools for < 25% of bowel
movements.
IBS with diarrhea (IBS-D) Loose (mushy) or watery stools for ≥ 25% of bowel movements and hard or lumpy stool for < 25% of bowel
movements.
Mixed IBS (IBS-M) Hard or lumpy stools for ≥ 25% of bowel movements and loose (mushy) or watery stools for ≥ 25% of bowel
movements.
Unsubtyped IBS Insufficient abnormality of stool consistency to meet criteria for IBSC, IBS-D or IBS-M.
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attending physician as suffering from psychiatric pro-
blems [22,23]. Similarly, physicians were shown to
detect only one-third of all cases in somatoform disor-
ders [24]. Therefore, psychological assessment should be
mandatory in patients with functional bowel disorders.
The screening of patients for anxiety and depression can
be performed easily through patient questionnaires and
is the basis and justification for additional therapeutic
interventions, which have been shown to be effective in
the GI symptom severity and quality of life of the IBS
patients [14,25-27]. At the present time, the treatment
of IBS patients in clinical practices focuses on physical
symptom relief. The efficacy of various medical and
dietary treatments has not been established [21,28] in
contrast to the efficacy of various psychological inter-
ventions. Recently, Zijdenbos et al. [27] suggested that
psychological interventions are superior to “care as
usual” for improvement of symptoms. In a systematic
review and meta- analysis Ford et al. demonstrated a
significant benefit of antidepressants over the placebo,
and psychological therapies over control therapy or a
physician’s “usual management”, for the treatment of
IBS [25].
In our study, the prevalence of psychiatric disorders
in IBS patients was evaluated in Guilan, a northern
province of Iran. Among 256 IBS patients that partici-
pated in this survey, 190 (74.2%) had one of the anxi-
ety-depressive disorders. Approximately 3 of 5 IBS
patients in our study had at least one kind of anxiety
disorder and 2 showed some degree of depression. The
main findings of our study were the importance of
psychiatric disorders, and especially anxiety, in the
severity of IBS. Most IBS patients with anxiety were
married, had a higher level of education, were unem-
ployed, suffered from IBS-D and had severe symptoms.
The high prevalence of anxiety and depression in the
local general population (20.8% and 21%, respectively)
[15] must be considered as an important factor in the
higher prevalence of these diseases in our studied IBS
patient group (35.5% and 16%, respectively). Studies
with an adequate number of patients and a standar-
dized psychiatric interview indicated that 50% to 60%
of IBS patients in gastroenterology clinics have psy-
chiatric disorders. The proportion is similar in patients
entering treatment trials for IBS symptoms [29]. North
American studies have found that anxiety disorders are
highly prevalent in IBS outpatients (39.7-52.4%) [30].
However, we cannot exclude those patients recruited
via advertisement and have consulted a physician due
to their IBS symptoms previously. In this study, the
prevalence of anxiety-depressive disorders in IBS
patients was higher in females, which is similar to
Blanchard et al. study [31,32]. This difference may
explain by the higher prevalence of anxiety and depres-
sion in the female normal population [17,33,34]. Also,
the prevalence of IBS in general population has been
reported higher in women [35]. However, a previously
published paper, which examined gender differences
among IBS patients in degree of psychological distress,
concluded that it might be a function of the method of
measurement. This means that by employing some
validated tests, such as the Beck Depression Inventory
(BDI), State-Trait Anxiety Inventory (STAI), or Minne-
sota Multiphasic Personality Inventory (MMPI), female
IBS patients showed more psychological distress. How-
ever, by using the categorical approach of the DSMs, it
seems that male and female IBS patients do not differ
[30].
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Figure 2 Distribution of psychiatric disorders and severity of
IBS between females and males.
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Table 3 Different variables among IBS patient with or without anxiety/depressive disorder
Variable Group Presence of Anxiety/Depressive isorder(256) P-value*
Negative(66) Positive(190)
Gender Male 34 (34%) 66 (66%) 0.016
Female 32 (20.5%) 124 (79.5%)
Marital Status Single 16 (34.8%) 30 (65.2%) 0.445
Married 49 (23.9%) 156 (76.1%)
Widow or 1 (20%) 4 (80%)
Divorce
Occupational Status Jobless 27 (18.4%) 120 (81.6%) 0.002
Has a job 39 (35.8%) 70 (64.2%)
Type of IBS Diarrhea 24 (21.4%) 88 (78.6%) 0.11
Constipation 34 (32.7%) 70 (67.3%)
Mixed 8 (20%) 32 (80%)
Severity of disease Mild 32 (47.8%) 35 (52.2%) 0.001
Moderate 34 (20.4%) 133 (79.6%)
Severe 0 22 (100%)
Educational Status Under diploma 25 (21%) 94 (79%) 0.104
Diploma or higher 41 (29.9%) 96 (70.1%)
Age group < 21 3 (25%) 9 (75%) 0.971
21-39 39 (26.4%) 109 (73.6%)
≥ 40 24 (25%) 72 (75%)
*P-values > 0.05 are considered non-significant (NS)
Table 4 Distribution of different variables among IBS patient with anxiety-depressive disorders
Variable Group Anxiety-depressive disorders(190) P-value* P-value**
Anxiety(89) Depression(41) Co- morbid(60)
Gender Male 35(53.1%) 15 (22.7%) 16 (24.2%) 0.765*** 0.271
Female 54(43.5%) 26 (21%) 44 (35.5%)
Marital Status Single 19(63.3%) 3 (10%) 8 (26.7%) < 0.01 0.104
Married 70(44.9%) 36 (23.1%) 50 (32%)
Widow or divorce 0 2 (50%) 2 (50%)
Occupational Status Jobless 56(46.7%) 23 (19.2%) 41 (34.2%) 0.459 0.456
Has a job 33(47.1%) 18 (25.7%) 19 (27.2%)
Type of IBS Diarrhea 50(56.8%) 12 (13.7%) 26 (29.5%) < 0.01 0.02
Constipation 25(35.7%) 18 (35.7%) 27 (38.5%)
Mixed 14(43.7%) 11 (34.4%) 7 (21.9%)
Severity of disease Mild 17(48.5%) 4 (11.4%) 14 (40.1%) 0.39 0.189
Moderate 59(44.3%) 31 (23.3%) 43 (32.3%)
Severe 13(59.1%) 6 (27.3%) 3 (13.7%)
Educational Status Under diploma 37(39.4%) 26 (27.7%) 31 (33%) 0.02 < 0.05
Diploma or higher 52(54.2%) 15 (15.6%) 29 (30.3%)
Age group < 21 6 (64.7%) 0 3 (33.3%) < 0.01 < 0.01
21-39 62(56.9%) 16 (14.6%) 31 (28.5%)
≥ 40 21(29.3%) 25 (34.8%) 26 (36%)
*P-values represent differences between anxiety and depression
**P-values represent differences in anxiety-depressive disorders
***P-values > 0.05 are considered non-significant (NS)
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In our study the presence of possible depression, as
well as a higher mean level of depression symptoms,
was more frequent in females than males, but was not
statistically significant. This was similar to Cain et al.
study, [36] in which no sex differences were found with
regard to depression symptoms in IBS patients. Possible
anxiety disorders showed a trend to be more prevalent
in female patients in our study. Also, the mean level of
anxiety symptoms was not different between males and
females. The most frequent type of anxiety disorder in
our study was GAD, which is consistent with previously
reported data [31,37]. In our analysis, comparing IBS
patients with and without psychiatric disorders, a signifi-
cant association with the severity of the disease has been
observed (P < 0.001). This might be considered as clear
evidence that all IBS patients who suffer from a severe
type of disease could have some degrees of anxiety-
depressive disorder.
Recent published results by Thijssen et al. showed the
importance of anxiety and depression on quality of life
and symptom severity in IBS patients. IBS patients with
anxiety disorder or depression had more severe symp-
toms, a worse physical and mental quality of life score,
and higher levels of dysfunctional cognition [38]. It has
also been suggested that anxiety about gastrointestinal
symptoms, not general anxiety or depression, may be
more relevant for symptom severity and health out-
comes in IBS and other functional GI disorders [39].
Comparing IBS patients with depression (41 cases) to
IBS patient without anxiety-depressive disorders (66
cases), depressed patients were older (P = 0.033), more
frequently married (P = 0.014), suffered more from a
severe type of IBS (P < 0.001) and had a lower educa-
tional level (P = 0.016). It seems that there is a high pre-
valence of depressive disorder in our society [15] and
the relation between depression and age, educational
level, marital and job status have some confounding
effects on observed results in our study.
Psychosocial stress and psychopathology are increased
in functional disorders, but not in all individuals, and is
generally thought of as being a cause rather than the
consequence of functional disorders [40]. This study
may provide indicative evidence for IBS as a disorder
with a psychosomatic aspect.
Although research methodology, study population,
measuring tools, sampling and sample sizes are some
factors that may influence the outputs of surveys, we
may suggest that the severity of IBS has a significant
relation with the presence of anxiety-depressive disor-
ders. Patients who suffer from possible anxiety disorders
or depression had more severe symptoms. Suffering
from a possible anxiety disorder independently influ-
ences IBS patients and may have a significant impact on
symptom severity. The distribution of these psychiatric
problems among our patients had some relation with
their age, educational level and type of IBS.
A possible limitation of this study is the recruitment
of patient data from a two-step examination. However,
this is unlikely to have any effects on the outcome. We
believe that GHQ28is a legitimate test, however in
patients with scores < 23 performing DSM IV-TR would
be more effective. Different commodity variables could
increase the prevalence of mood disorders but these
results should be interpreted with a great caution and
would need more researches in the future.
Conclusion
There was a high prevalence of anxiety-depressive disor-
ders in our subjects. Age, educational level and type and
severity of IBS had remarkable distributional differences
among the studied groups. Also, psychological factors
influence symptom severity in IBS patients. This data
emphasize the importance of the psychological evalua-
tion of the patients with IBS to identify those who
might be suffering from psychological disorders in order
to better management of the patients and may also help
to reduce the burden of health care costs.
Further studies will be needed to assess the outcome
of the psychiatric evaluation and treatment in symptom
relief of the IBS patients.
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